Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Prostate Cancer”

1,438 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,438 results

Testing effectiveness (Phase 2)Study completedNCT00005028
What this trial is testing

Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Maryland, Baltimore 46
Testing effectiveness (Phase 2)Study completedNCT00140348
What this trial is testing

Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine

Who this might be right for
Prostate Cancer
Cell Genesys 80
Not applicableStudy completedNCT00416390
What this trial is testing

Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia

Who this might be right for
Nonmalignant NeoplasmProstate Cancer
University of Illinois at Chicago 120
Testing effectiveness (Phase 2)Ended earlyNCT01200810
What this trial is testing

Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT00005848
What this trial is testing

R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Fox Chase Cancer Center 7
Not applicableNot Yet RecruitingNCT07237399
What this trial is testing

Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM)

Who this might be right for
Oligometastatic Prostate Cancer (OMPC)Prostate Cancer (Adenocarcinoma)Ablation Techniques
University Hospital, Ghent 50
Testing effectiveness (Phase 2)Study completedNCT00284752
What this trial is testing

Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Kaiser Permanente 56
Testing effectiveness (Phase 2)WithdrawnNCT00811031
What this trial is testing

Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02268175
What this trial is testing

Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate

Who this might be right for
Prostate AdenocarcinomaProstate CancerHigh Risk Prostate Cancer
Dana-Farber Cancer Institute 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT05670106
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT00329043
What this trial is testing

Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)Study completedNCT00587964
What this trial is testing

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Who this might be right for
Brain MetastasisBladder CancerBreast Cancer+10 more
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Looking for participantsNCT06798558
What this trial is testing

Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

Who this might be right for
Prostate Adenocarcinoma
Hackensack Meridian Health 54
Testing effectiveness (Phase 2)Study completedNCT02789878
What this trial is testing

Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Instituto do Cancer do Estado de São Paulo 64
Testing effectiveness (Phase 2)Ended earlyNCT01928485
What this trial is testing

Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer

Who this might be right for
Stage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer
Sanjay Gupta PhD 6
Not applicableStudy completedNCT06016725
What this trial is testing

Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+6 more
Ohio State University Comprehensive Cancer Center 75
Testing effectiveness (Phase 2)Ended earlyNCT01828476
What this trial is testing

Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 13
Testing effectiveness (Phase 2)UnknownNCT02724618
What this trial is testing

Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)

Who this might be right for
Prostate Cancer
Shahid Beheshti University of Medical Sciences 64
Testing effectiveness (Phase 2)Ended earlyNCT03211052
What this trial is testing

Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alone

Who this might be right for
Prostate Cancer
Centre of Experimental Medicine 16
Testing effectiveness (Phase 2)Ended earlyNCT00313482
What this trial is testing

PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC

Who this might be right for
Hormone Refractory Prostate Cancer
Veeda Oncology 35
Load More Results